NASDAQ:ASTH
Astrana Health, Inc.
Astrana Health, Inc.'s revenue grew 56.4% in fiscal 2025 to $3.2B while operating margin fell to 2.5%, its lowest in 10 years. Free cash flow was $104.5M, 3.3% of revenue, and the diluted share count rose 2.9%.Summary generated from Astrana Health, Inc.'s SEC filings. Latest annual report filed Mar 12, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$3.2B
Revenue growth+56.4%
Revenue, 5-yr CAGR+35.9%
Gross marginn/a
Operating margin2.5%
Net margin0.7%
ROIC4.2%
Return on equity3.0%
Debt / equity1.33
Free cash flow$104.5M
FCF margin3.3%
Share count change+2.9%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 774 | 1,144 | 1,387 | 2,035 | 3,182 |
| Operating income | 98 | 104 | 85 | 89 | 79 |
| Net income | 69 | 45 | 61 | 43 | 22 |
| Free cash flow | 51 | 59 | 40 | 44 | 104 |
Recent filings
- 4Insider transaction report
Oct 8, 2026 - 4Insider transaction report
Oct 8, 2026 - 8-KRegulation FD disclosure
Sep 23, 2026 - 8-KCurrent report
Sep 23, 2026 - 8-KRegulation FD disclosure
Sep 15, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 10, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 8-KRegulation FD disclosure
Jul 13, 2026